Lataa...
Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy()
Over the past decade, inhibition of the kinase activities of oncogenic proteins using small molecules and antibodies has been a mainstay of our anticancer drug development effort, resulting in several Food and Drug Administration–approved cancer therapies. The clinical effectiveness of kinase-target...
Tallennettuna:
| Julkaisussa: | Neoplasia |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Neoplasia Press
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4611070/ https://ncbi.nlm.nih.gov/pubmed/26476077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2015.08.008 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|